Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BMP-binding endothelial regulator protein (BMPER) is a secreted extracellular matrix glycoprotein expressed by endothelial cell precursors and mature endothelial cells. It contains five cysteine-rich domains, a von Willebrand D domain, and a trypsin inhibitor domain, and is orthologous to Drosophila crossveinless-2. BMPER directly binds BMP2, BMP4, and BMP6, and finely tunes their signaling in a highly context-dependent manner, acting as either an antagonist or agonist of BMP-mediated Smad1/5 activation. It plays a vital role in blood vessel formation, endothelial cell migration, embryonic vascular development, and also interacts with metabolic and insulin signaling pathways. BMPER modulates angiogenesis by dose-dependent regulation of BMP activity and is considered a potential therapeutic target for vascular diseases and metabolic disorders[1][2][3][4][5].
Not applicable, as no direct drugs targeting BMPER are reported or approved. Existing research focuses on BMPER modulation of BMP ligands and their receptors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BMP-binding endothelial regulator protein (BMPER).